Highlights

  • Wesfarmers reported revenue of A$45.70 billion and net profit of A$2.92 billion for the latest reported financial year.
  • The company outlined expansion plans for its WesCEF business, including progress on the Mt Holland lithium project and capacity increases for key chemical products.
  • Wesfarmers also detailed a multi-year strategy to expand its Health division through store growth, digital capabilities and operational improvements.
  • Recent updates highlight the company's continued focus on business expansion and operational development across multiple divisions.

Wesfarmers Limited (ASX: WES) operates within the Consumer Discretionary Distribution & Retail industry and manages a diversified portfolio of businesses across retail and industrial operations. The company continues to invest in business expansion, operational efficiency and long-term growth initiatives across several divisions.

This article reviews Wesfarmers' reported financial performance, historical revenue and net profit trend, and recent company updates. It is based solely on the information provided and is intended for educational purposes only. It should not be considered financial or investment advice.

Financial Performance Overview

For the latest reported financial year, Wesfarmers reported revenue of A$45.70 billion, net profit of A$2.92 billion and earnings per share (EPS) of A$2.700.

Reviewing financial performance across multiple reporting periods provides additional context for understanding changes in the company's reported operations and financial results.

Revenue and Net Profit Trend

Wesfarmers' reported financial results show revenue and net profit increasing across the four financial years presented.

For June 2022, the company reported revenue of A$36.83 billion and net profit of A$2.35 billion. In June 2023, revenue increased to A$43.55 billion, while net profit rose to A$2.46 billion.

For June 2024, Wesfarmers reported revenue of A$44.18 billion and net profit of A$2.55 billion. In the latest reported financial year ended June 2025, revenue increased to A$45.70 billion, while net profit reached A$2.92 billion.

These figures provide a historical overview of the company's reported financial performance across recent financial years.

Recent Company Updates

Wesfarmers provided an update on several WesCEF growth initiatives. The company said the Mt Holland lithium project expansion is progressing towards a Final Investment Decision (FID) in the first half of FY27. According to the company, the proposed expansion is designed to increase spodumene concentrate production to approximately 760 thousand tonnes per annum (ktpa), improve recoveries through an ore sorter and reduce production costs, with construction targeted for completion during calendar year 2029.

The company also highlighted recent capacity expansion projects within WesCEF, including completion of the Nitric Acid Ammonium Nitrate (NAAN3) debottlenecking project, increasing ammonium nitrate production capacity to approximately 865ktpa, along with the first phase of its sodium cyanide expansion, lifting total production capacity to around 130ktpa. Management said the benefits from these expanded production capacities are expected to begin from FY27, while the Mt Holland refinery ramp-up remains a key focus.

Separately, Wesfarmers outlined a multi-year strategy for its Health division, centred on expanding the Priceline Pharmacy network, strengthening omnichannel capabilities, enhancing loyalty and digital platforms, improving wholesale efficiency and growing its Digital Health and MediAesthetics businesses.

During FY26, the company completed 24 new Priceline Pharmacy sites and 23 store refurbishments. It also launched a new customer application, expanded health service offerings and continued investing in supply chain automation, digital capabilities and operational efficiency initiatives.

Industry Overview

Wesfarmers operates within the Consumer Discretionary Distribution & Retail industry, which includes businesses involved in retail operations, consumer products and related services. Companies operating in this sector are influenced by consumer spending patterns, operational efficiency, digital transformation, inventory management and investment in store networks and customer experience.

Large diversified retailers often continue to invest in technology, supply chain capabilities and business expansion to support long-term operations across multiple business segments.

Understanding the Latest Developments

The company's recent updates highlight ongoing investment across both its industrial and retail operations. While the WesCEF initiatives focus on expanding production capacity and supporting future operational development, the Health division strategy emphasises retail expansion, digital capabilities and customer engagement initiatives.

Together with the company's reported financial performance, these updates provide additional context for understanding Wesfarmers' reported business priorities and long-term operational plans.

Conclusion

Wesfarmers Limited's reported financial performance and recent company updates provide an overview of its diversified operations and long-term business initiatives. The company continues to outline plans relating to production capacity, retail expansion, technology investment and operational development across multiple divisions.

This article is based solely on the information provided and is intended for educational and informational purposes only. It should not be considered financial or investment advice.